Literature DB >> 21228579

Development of a peritoneal dialysis program.

Fredric O Finkelstein1, Ojo Olalekan Ezekiel, Radu Raducu.   

Abstract

The development of a successful peritoneal dialysis program requires that the organization and structure of the program be carefully planned. Key ingredients include developing a robust chronic kidney disease education program, adequate training for physicians and nurses, full complement of supporting staff (including nurses, dietician, and social worker), appropriate continuous quality improvement programs, and a reasonable program size.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21228579     DOI: 10.1159/000321847

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  4 in total

1.  Using a multidisciplinary training program to reduce peritonitis in peritoneal dialysis patients.

Authors:  Liliana Gadola; Carla Poggi; María Poggio; Lucía Sáez; Alejandra Ferrari; Jorge Romero; Soledad Fumero; Gianella Ghelfi; Liliana Chifflet; Patricia Larre Borges
Journal:  Perit Dial Int       Date:  2012-07-01       Impact factor: 1.756

Review 2.  Setting Up and Expanding a Home Dialysis Program: Is There a Recipe for Success?

Authors:  Masood Ahmad; Eric L Wallace; Gaurav Jain
Journal:  Kidney360       Date:  2020-05-01

3.  Through the Patients' Eyes: The Experience of End-Stage Renal Disease Patients Concerning the Provided Nursing Care.

Authors:  Areti Stavropoulou; Maria G Grammatikopoulou; Michail Rovithis; Konstantina Kyriakidi; Andriani Pylarinou; Anastasia G Markaki
Journal:  Healthcare (Basel)       Date:  2017-07-21

4.  Multidimensional analysis of factors responsible for the low prevalence of ambulatory peritoneal dialysis in Germany (MAU-PD): a cross-sectional Mixed-Methods Study Protocol.

Authors:  Nadine Scholten; Tim Ohnhaeuser; Isabell Schellartz; Gero von Gersdorff; Martin Hellmich; Ute Karbach; Holger Pfaff; Christina Samel; Stephanie Stock; Katherine Rascher; Thomas Mettang
Journal:  BMJ Open       Date:  2019-04-20       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.